Piclidenoson reached its primary endpoint with a statistical difference over placebo while showing a very good safety profile but did not outperform apremilast.
Deucravacitinib performed with durable efficacy. Up to week 112, results in various outcome measures were consistent with those at week 52.
Biologics were recently approved for hidradenitis suppurativa, but many patients who do not respond efficiently experience a significant disease burden.
Excessive salt and alcohol consumption can trigger unpleasant events. One of these is the little-noticed Holiday Heart Syndrome.
Associate Prof. Vaghefi discusses AI retina scan algorithms, how the retina can detect other health issues, and how the retinal tech was deployed in rural India.
Ritlecitinib sustained efficacy in treatment up to month 36 without new safety signals. Patient-reported outcomes improved already after 3 months.
Overall survival seems numerically longer with abemaciclib + NSAI in post-menopausal patients with HR-positive / HER2-negative advanced breast cancer.
Skin cancer prevention campaigns remain unsuccessful, a survey of 17,000 people from 17 countries showed. Many myths regarding sun exposure still hold.
Patients with TNBC with over 40% Tumour Infiltrating Lymphocytes in their tumour, respond well on neoadjuvant immune checkpoint blockade.
Infants with high risk of atopic dermatitis that started an 8-week intervention with emollients directly after birth, had a significant risk reduction for AD.
A statement by an Italian physician association president on "indecorous" physicians’ photos, opens a wider debate on professional decorum and dignity.
A one-time colonoscopy for screening entailed an 18% risk reduction of incidence in colorectal cancer (CRC) compared with no screening.
Studies confirm time and again that men tend to avoid visits to their physicians more often than women. Why is that?
Cabozantinib/ nivolumab/ipilimumab improves progression-free survival versus dual nivolumab/ipilimumab in untreated advanced renal cell carcinoma.
Both antibiotic use and days with antibiotic use could be markedly reduced with the help of a procalcitonin-based algorithm.
Phase 3 Checkmate 914 trial showed that the adjuvant treatment does not improve survival for stage II–III localised RCC, which has high post-nephrectomy risk.
In Antarctica, thirteen people are cut off from the world for nine months. Among them, a physician with heavy duties, yet in an extraordinary adventure.
Early surgery might benefit Crohn's patients, but identifying exact patient groups who will benefit from early surgery requires prospective studies.
Compared to conventional colonoscopy, the addition of artificial intelligence entailed significantly higher detection and lower rates of missed adenomas.
Second-line treatment with TIL improves PFS compared with ipilimumab in patients with advanced, non-resectable stage III–IV melanoma.